key: cord-0785484-55sr71ln
authors: Muñoz-Basagoiti, Jordana; Perez-Zsolt, Daniel; León, Rubén; Blanc, Vanessa; Raïch-Regué, Dàlia; Cano-Sarabia, Mary; Trinité, Benjamin; Pradenas, Edwards; Blanco, Julià; Gispert, Joan; Clotet, Bonaventura; Izquierdo-Useros, Nuria
title: Cetylpyridinium chloride-containing mouthwashes reduce the infectivity of SARS-CoV-2 variants in vitro
date: 2021-03-15
journal: bioRxiv
DOI: 10.1101/2020.12.21.423779
sha: b4bfb34c81b6b2ac45221172c5c811cf4d14efbb
doc_id: 785484
cord_uid: 55sr71ln

Oral mouthwashes decrease the infectivity of several respiratory viruses including SARS-CoV-2. However, the precise agents with antiviral activity present in these oral rinses and their exact mechanism of action remain unknown. Here we show that Cetylpyridinium chloride (CPC), a quaternary ammonium compound present in many oral mouthwashes, reduces SARS-CoV-2 infectivity by inhibiting the viral fusion step with target cells after disrupting the integrity of the viral envelope. We also found that CPC-containing mouth rinses decreased more than a thousand times the infectivity of SARS-CoV-2 in vitro, while the corresponding vehicles had no effect. This activity was effective for different SARS-CoV-2 variants, including the B.1.1.7 variant, predominant in UK, also in the presence of sterilized saliva. CPC-containing mouth rinses could therefore represent a cost-effective measure to reduce SARS-CoV-2 infectivity in saliva, aiding to reduce viral transmission from infected individuals regardless of the variants they are infected with.

Oral mouthwashes decrease the infectivity of several respiratory viruses including SARS-22

CoV-2. However, the precise agents with antiviral activity present in these oral rinses and 23 their exact mechanism of action remain unknown. Here we show that Cetylpyridinium 24 chloride (CPC), a quaternary ammonium compound present in many oral mouthwashes, 25 reduces SARS-CoV-2 infectivity by inhibiting the viral fusion step with target cells after 26 disrupting the integrity of the viral envelope. We also found that CPC-containing mouth 27 rinses decreased more than a thousand times the infectivity of SARS-CoV-2 in vitro, 28 while the corresponding vehicles had no effect. This activity was effective for different Here we focused on the effect of Cetylpyridinium chloride (CPC), a quaternary 59 ammonium compound used in many oral mouthwashes and breath sprays with broad 60 antiseptic and microbicide activity. We compared the anti-SARS-CoV-2 activity of CPC 61 and CPC-containing mouthwashes against their respective vehicles, and found that CPC-62 containing mouthwashes inhibit SARS-CoV-2 entry into target cells after disrupting the 63 integrity of the viral membrane. CPC-containing mouth washes decreased more than a 64 thousand times the infectivity of replication competent SARS-CoV-2 viruses, were active 65 formulations were also mixed with media, washed and centrifuged as previously 154 described, and were equally cultured on Vero E6, but in the absence of virus. Cytotoxic 155 effects of these products were measured 3 days after infection, using the CellTiter-Glo 156 luminescent cell viability assay (Promega). Luminescence was measured in a Fluoroskan 157 Ascent FL luminometer (ThermoFisher Scientific). The cytotoxicity obtained for each 158 compound tested determined the limit of detection of the assay. curve with variable slope. Cells exposed to the pseudovirus in the absence of products 183 were used as positive controls of infection, and were set as 100% of viral fusion to 184 normalize data and calculate the percentage of viral entry inhibition. Cells not exposed to 185 the mouthwashes nor to the pseudovirus were used as positive controls of viability, and 186

were set as 100% to normalize data and calculate the percentage of cytopathic effect. All 187 analyses and figures were generated with the GraphPad Prism v8.0b Software. 188

We first tested the capacity of CPC-containing mouth rinses to inhibit SARS-CoV-2 entry 190 into target cells. We employed a luciferase-based assay, using a using a reporter lentivirus 191 pseudotyped with the spike protein of SARS-CoV-2, which allows the detection of viral directly tested this compound resuspended in water, and found that it also inhibited 206 SARS-CoV-2 pseudoviral fusion and entry into target cells ( Figure 1G) . We also assayed 207 the capacity of CPC-containing mouth rinses to reduce the fusion of pseudoviruses 208 displaying different SARS-CoV-2 Spikes, including the D614G mutation and the full 209 B.1.1.7 variant, which has become predominant in UK, and whose higher transmissibility 210 and pathogenicity are a global concern [6]. Yet, a CPC-containing mouthwash was 211 equally effective in abrogating the entry of pseudoviruses expressing each spike these 212 variants ( Figure 1H) . These results indicate that CPC-containing mouth rinses are able 213 to block SARS-CoV-2 viral entry into target cells due to the activity of CPC, which is 214 efficacious against different variants. assayed with an ELISA that detects SARS-CoV-2 nucleocapsid, but in absence of the 224 detergent used to lyse the viruses in the conventional protocol (Figure 2A) . In the absence 225 of the lysis buffer, viruses treated with CPC-containing mouthwash were detected to a 226 much higher extent than untreated viruses, regardless of the variant tested ( Figure 2B) . 227

Of note, addition of the ELISA assay buffer containing detergents in untreated viruses 228 increased nucleoprotein detection (Figure 2C ), but not to the extent of CPC-containing 229

mouthwashes. In addition, we measured the impact of CPC treatment on the zeta potential 230 and size distribution of viral particle s( Figure 2D and Table 1 ). Each viral variant was 231 treated with CPC 10 mM at a 1 to 1 volume ratio for 2 minutes, fixed with 232 paraformaldehyde and analyzed by two light scattering methods. Using electrophoretic 233 light scattering (ELS), we found that upon CPC treatment, the zeta potential of untreated 234 viruses that was originally electronegative increased exponentially ( Table 1) . Moreover, 235 this treatment broadened the viral size distribution in both types of SARS-CoV-2 variants 236 ( Figure 2D and Table 1) , while CPC or paraformaldehyde alone had a narrower and 237 smaller distinctive profile ( Figure 2D and Table 1 we mixed equal volumes of highly infectious SARS-CoV-2 viral variants with CPC-308 containing mouthwashes, these treatments reduced more than 1,000 times the TCID50 309 while corresponding vehicles had no impact. Since virucidal activity with a CPC-310 containing oral rinse was equally effective when saliva was added, this suggest that CPC-311 containing mouthwashes will most likely be active in the oral cavity. shown that CPC has an anti-bacterial activity that last for 3 to 5 hours in saliva [18] , 328

forthcoming studies should address the duration of the CPC antiviral activity in the oral 329 cavity. This information will be key to effectively validate this approach as a mean to 330 maintain a reduced infectious capacity of SARS-CoV-2 in the saliva with this cost-331 effective intervention. 332 FIGURES 333

entry. Percentage of viral entry inhibition on target HEK-293T cells expressing ACE2 335 exposed to a fixed concentration of SARS-CoV-2 in the presence of increasing 336 concentrations of oral formulations (A, C, E), their vehicles (B, D, F) and CPC diluted 337 in water (G). Non-linear fit to a variable response curve from one experiment with two 338

replicates is shown (red lines), excluding data from drug concentrations with associated 339 toxicity. When calculated, the particular IC50 value of the graph is indicated. Cytotoxic 340 effect on HEK-293T cells expressing ACE2 cells exposed to increasing concentrations 341 of mouthwashes or vehicles in the absence of virus is also shown (grey lines). H. 342

Percentage of viral entry inhibition on target HEK-293T cells expressing ACE2 exposed we confirmed that the inhibitory effect was not due to any remaining cytotoxic effect of 370 the mouthwashes, as tested on Vero E6 cells exposed to the media left from washed mouth 371 rinses that were equally centrifuged in the absence of virus. The cytotoxicity obtained for 372 each compound tested determined the detection limit of the assay, which is represented 373 with a shaded red area. Of note, equivalent decrease in TCID50 was obtained when viral 374 stocks were mixed at a 1 to 10 volume ratio with CPC-containing mouthwashes (data not 

Virucidal Efficacy of Different Oral 406 Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2

Potential Role of Oral Rinses Targeting 409 the Viral Lipid Envelope in SARS-CoV-2 Infection

Rapid Activity Against Influenza Viruses in vitro and in vivo

The Virucidal Efficacy of Oral Rinse 414 Components Against SARS-CoV-2 In Vitro

Transmission of COVID-19 in 282 417 clusters in Catalonia, Spain: a cohort study

Estimated transmissibility and impact of 420 SARS-CoV-2 lineage B.1.1.7 in England

SARS-CoV-2 within-host diversity and 422 transmission

Antibody Resistance of SARS-CoV-2 Variants 424 B.1.351 and B.1.1.7. Nature

426 Risk of mortality in patients infected with SARS-CoV-2 variant of concern 427 202012/1: matched cohort study

Characterization of spike glycoprotein of SARS-CoV-2 on 429 virus entry and its immune cross-reactivity with SARS-CoV

SARS-CoV-2 infection elicits a rapid 432 neutralizing antibody response that correlates with disease severity

Stable neutralizing antibody levels six months 435 after mild and severe COVID-19 episode

Identification of Plitidepsin as Potent Inhibitor of 437 SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen

Virological assessment of hospitalized 440 patients with COVID-2019

High SARS-CoV-2 Attack Rate Following 442 Exposure at a Choir Practice

Phylogenetic analysis of SARS-CoV-2 in 445

Viable SARS-CoV-2 in various specimens 447 from COVID-19 patients

The Substantivity 449 of a Number of Oral Hygiene Products Determined by the Duration of Effects on 450 Salivary Bacteria